Company news

Mabion SA news in 2026

Mabion SA's news releases, calls and decks from 2026, newest first.

View company

Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia

August 26, 2026

Other information to the quarterly report of Mabion S.A. for Q1 2026

May 19, 2026

Interim condensed financial statements for the 3-month period ended 31 March 2026

May 19, 2026

Mabion: Financial statements for the financial year ended 31 December 2025

April 29, 2026

Presentation of financial results for FY 2025 – Mabion

April 28, 2026

Mabion: Directors’ Report for the year 2025

April 28, 2026

Directors report for the year 2025

April 28, 2026

Decks in 2026